About Dave Adams
Form D filings for Myosin Therapeutics in 2023 list Dave Adams as director.
Dave Adams first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Dave Adams in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Dave Adams works with at each company, as listed on that company's latest Form D.
Myosin Therapeutics Inc. · Form D/A, Mar 24, 2023
PD
Patrick Griffin, Ph.D.
Director
AR
Andrew Ritter
Director
CM
Courtney Miller
President and director
RF
Robert Finizio
Director
TK
Theodore Kamenecka
Director
JS
Jackson Streeter
Director